Email alerts
Advanced Search
Your search returned 130 results
  • Feb 21, 2017
    Medtronic Reports Third Quarter Financial Results
    Revenue of $7.3 Billion Grew 5% as Reported; 6% at Constant Currency

    DUBLIN - February 21, 2017 - Medtronic plc (NYSE: MDT) today announced financial results for its third quarter of fiscal year 2017, which ended January 27, 2017. The company reported third quarter...

  • Feb 16, 2017
    Medtronic Introduces Signia(TM) Stapling System, Innovative Surgical Stapler for Minimally Invasive Surgery
    New Single-Handed Powered Stapling System Provides Real-time Feedback During Surgery1

    DUBLIN - Feb. 15, 2017 - Medtronic plc (NYSE: MDT) today announced that the U.S. Food and Drug Administration (FDA) has cleared an expanded indication for the OsteoCool(TM) RF Ablation System....

  • Feb 1, 2017
    Medtronic CardioInsight Mapping Solution Cleared by FDA
    System First Used Commercially in U.S. This Week

    DUBLIN - Feb. 1, 2017 - Medtronic plc (NYSE: MDT) has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the CardioInsight(TM) Noninvasive 3D Mapping System. The CardioInsight...

  • Nov 22, 2016
    Medtronic Reports Second Quarter Financial Results
    Revenue of $7.3 Billion Grew 4% as Reported; 3% at Constant Currency

    DUBLIN - November 22, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its second quarter of fiscal year 2017, which ended October 28, 2016. The company reported second...

  • Nov 16, 2016
    Medtronic Releases FY16 Integrated Performance Report
    Report Highlights Company's Global Financial, Social, and Environmental Impact

    DUBLIN - Nov. 16, 2016 - Medtronic plc (NYSE:MDT) announces the release of its 2016 Integrated Performance Report. The report highlights - for the first time - the combined financial, social, and...

  • Oct 31, 2016
    First Clinical Data of Medtronic Drug-Filled Stent Show Positive Outcomes
    Featured 'First Report' RevElution Trial at TCT Highlights the Potential Benefits of First-of-its-Kind Polymer-Free Technology with Controlled and Sustained Drug Delivery for Rapid Vessel Healing

    DUBLIN and WASHINGTON, D.C. - Oct. 31, 2016 - Medtronic plc (NYSE: MDT) unveiled today the first clinical outcomes of its novel Drug-Filled Stent (DFS) from the RevElution Trial at the...

  • Sep 30, 2016
    FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls

    DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have...

  • Aug 25, 2016
    Medtronic Reports First Quarter Financial Results
    Revenue of $7.2 Billion Decreased 1% as Reported; Prior Year Had Extra Selling Week

    DUBLIN - August 25, 2016 - Medtronic plc (NYSE: MDT) today announced financial results for its first quarter of fiscal year 2017, which ended July 29, 2016. The company reported first quarter...

  • Jul 28, 2016
    HeartWare International Reports $68.7 Million In Second Quarter 2016 Revenue
    - Global revenue increased approximately 25% from first quarter of 2016

    HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less-invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure,...

  • Jun 27, 2016
    Medtronic to Expand Heart Failure Portfolio with Acquisition of Heartware International
    Extends Clinical and Commercial Leadership Into Growing Circulatory Support Sector

    DUBLIN and FRAMINGHAM, Mass. - June 27, 2016 - Medtronic plc (NYSE: MDT), the global leader in medical technology, and HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of...

Show 5102550100 per page